HETEROCYCLYL ANTHRACYCLINONE DERIVATIVES
    2.
    发明授权
    HETEROCYCLYL ANTHRACYCLINONE DERIVATIVES 有权
    杂环ANTHRACYCLINONDERIVATE

    公开(公告)号:EP1062212B1

    公开(公告)日:2004-05-12

    申请号:EP99915564.1

    申请日:1999-03-04

    摘要: A compound of formula (1) wherein R1 is hydrogen, hydroxy, a group of formula OR5 wherein R5 is C1-C6 alkyl, C2-C6 alkenyl or C3-C8 cycloalkyl, halogen, amino which may be unsubstituted or mono or disubstituted by C1-C6 alkyl, C2-C6 alkenyl, aralkyl, acyl or trifluoroacetyl; R2 is hydrogen, hydroxy, a group NR6R7 wherein R6 and R7 independently represent hydrogen, an optionally substituted C1-C6 alkyl, C2-C6 alkenyl, C3-C8 cycloalkyl or, taken together with the nitrogen atom, represent an optionally substituted C3-C8 heterocyclic ring; R3 is hydrogen, hydroxy; R4 is a 2-substituted thiazolyl or imidazolyl system and the pharmaceutically acceptable salt thereof, is useful in the treatment of amyloidosis. Processes for the preparation and pharmaceutical compositions are also described.

    AMINO ANTHRACYCLINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF AMYLOIDOSIS
    4.
    发明授权
    AMINO ANTHRACYCLINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF AMYLOIDOSIS 有权
    AMINOANTHRACYCLINONDERIVATE及其用于治疗淀粉样变性

    公开(公告)号:EP1062206B1

    公开(公告)日:2004-04-14

    申请号:EP99910304.7

    申请日:1999-02-25

    CPC分类号: C07D405/06 C07D211/70

    摘要: A compound of formula (1), wherein R1 represents hydrogen, hydroxy, a group of formula OR7, wherein R7 is C1-C6 alkyl, C2-C6 alkenyl; R2 represents hydrogen, hydroxy, diethylamino, piperidino, tetrahydropyridino or morpholino, and either R3, taken alone, represents hydrogen or hydroxy, and R4 and R5, taken alone, independently represent hydrogen, hydroxy or, taken together with the carbon atom, represent a carbonyl group; or R3 and R4, taken together, represent a group of formula (A), wherein R8 and R9 represent a C1-C6 alkyl and R5 represents hydrogen; R6 represents hydrogen or a phenyl group, optionally substituted by methyl, methoxy or halogen and the pharmaceutically acceptable salt thereof, is useful in the treatment of amyloidosis. Processes for the preparation and pharmaceutical compositions are also described.

    ABEO-ERGOLINE DERIVATIVES AS 5HT1A LIGANDS
    5.
    发明授权
    ABEO-ERGOLINE DERIVATIVES AS 5HT1A LIGANDS 失效
    ABEO麦角灵衍生物AS 5HT1A配体

    公开(公告)号:EP0708777B1

    公开(公告)日:2003-11-26

    申请号:EP95916653.9

    申请日:1995-04-13

    IPC分类号: C07D487/06 A61K31/40

    CPC分类号: C07D487/06

    摘要: There are provided compounds of formula (I), wherein R1 is a hydrogen, chlorine or bromine atom or a methyl, methylthio, hydroxy, cyano or carboxamido group; R2 is C1-C3 alkyl or an allyl group; R3 and R4 are independently a hydrogen atom, a C1-C5 alkyl group, a C3-C5 alkenyl group, a C5-C6 cycloalkyl C1-C3 alkyl group, a phenyl-C1-C3 alkyl, a phenyl -C3-C5 alkenyl or phenyl group: which groups are optionally substituted by C1-C3 alkyl, C1-C3 alkoxy, trifluoromethyl, hydroxy or amino group; or a group of formula (a), wherein R6 is hydrogen atom or a C1-C3 alkyl group and R7 is a phenyl group, a substituted phenyl group as described above or a heterocyclic ring, R5 is a hydrogen or bromine atom or an organic residue and R is H or an organic residue, or a pharmaceutically acceptable salt thereof. A process for their preparation and the pharmaceutical compositions comprising them are also provided.